img

Global Orexin Receptor Antagonists for Insomnia Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Orexin Receptor Antagonists for Insomnia Market Insights, Forecast to 2034

Suvoresan is believed to play a therapeutic role in the treatment of insomnia by blocking orexin receptors and inhibiting the effects of endogenous wake-promoting orexin neuropeptides OX-A and OX-B.
Global Orexin Receptor Antagonists for Insomnia market is expected to reach to US$ 1287 million in 2024, with a positive growth of %, compared with US$ 1100 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Orexin Receptor Antagonists for Insomnia industry is evaluated to reach US$ 3301.4 million in 2034. The CAGR will be 17.0% during 2024 to 2034.
Globally, Orexin Receptor Antagonists for Insomnia key manufacturers include MSD, Eisai Co., Ltd. and Idorsia, etc. MSD, Eisai Co., Ltd., Idorsia are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Orexin Receptor Antagonists for Insomnia were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034 and the sales share will be % in 2034. Moreover, China, plays a key role in the whole Orexin Receptor Antagonists for Insomnia market and estimated to attract more attentions from industry insiders and investors.
Orexin Receptor Antagonists for Insomnia can be divided into OX1R and OX2R, etc. OX1R is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2034.
Orexin Receptor Antagonists for Insomnia is widely used in various fields, such as Hospital, Clinic and Other,, etc. Hospital provides greatest supports to the Orexin Receptor Antagonists for Insomnia industry development. In 2022, global % sales of Orexin Receptor Antagonists for Insomnia went into Hospital filed and the proportion will reach to % in 2034.
Report Covers
This report presents an overview of global Orexin Receptor Antagonists for Insomnia market from 2024 to 2034, aiming to help readers to get a comprehensive understanding of global Orexin Receptor Antagonists for Insomnia market with multiple angles. Items like regional sales, revenue from 2024 to 2034 and manufacturers’ sales, price, revenue and gross margin from 2024 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2024 to 2034 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


MSD
Eisai Co., Ltd.
Idorsia
Segment by Type
OX1R
OX2R

Segment by Application


Hospital
Clinic
Other

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2024 to 2034
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Orexin Receptor Antagonists for Insomnia plant distribution, commercial date of Orexin Receptor Antagonists for Insomnia, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2024 to 2034 globally
Chapter 5Product sales, revenue and price analysis by application from 2024 to 2034 globally
Chapter 6Product sales, revenue analysis by type and application from 2024 to 2034 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2024 to 2034
Chapter 7Product sales, revenue analysis by type and application from 2024 to 2034 in Europe. Product sales and revenue analysis of each country in Europe from 2024 to 2034
Chapter 8Product sales, revenue analysis by type and application from 2024 to 2034 in China. Product sales and revenue analysis of China from 2024 to 2034
Chapter 9Product sales, revenue analysis by type and application from 2024 to 2034 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2024 to 2034
Chapter 10Product sales, revenue analysis by type and application from 2024 to 2034 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2024 to 2034.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Orexin Receptor Antagonists for Insomnia introduction, etc. Orexin Receptor Antagonists for Insomnia Sales, Revenue, Price and Gross Margin of each company from 2024 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Orexin Receptor Antagonists for Insomnia
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Orexin Receptor Antagonists for Insomnia Product Introduction
1.2 Market by Type
1.2.1 Global Orexin Receptor Antagonists for Insomnia Market Size Growth Rate by Type, 2024 VS 2022 VS 2034
1.2.2 OX1R
1.2.3 OX2R
1.3 Market by Application
1.3.1 Global Orexin Receptor Antagonists for Insomnia Market Size Growth Rate by Application, 2024 VS 2022 VS 2034
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Orexin Receptor Antagonists for Insomnia Sales Estimates and Forecasts 2024-2034
2.2 Global Orexin Receptor Antagonists for Insomnia Revenue by Region
2.2.1 Global Orexin Receptor Antagonists for Insomnia Revenue by Region: 2024 VS 2022 VS 2034
2.2.2 Global Orexin Receptor Antagonists for Insomnia Revenue by Region (2024-2024)
2.2.3 Global Orexin Receptor Antagonists for Insomnia Revenue by Region (2024-2034)
2.2.4 Global Orexin Receptor Antagonists for Insomnia Revenue Market Share by Region (2024-2034)
2.3 Global Orexin Receptor Antagonists for Insomnia Sales Estimates and Forecasts 2024-2034
2.4 Global Orexin Receptor Antagonists for Insomnia Sales by Region
2.4.1 Global Orexin Receptor Antagonists for Insomnia Sales by Region: 2024 VS 2022 VS 2034
2.4.2 Global Orexin Receptor Antagonists for Insomnia Sales by Region (2024-2024)
2.4.3 Global Orexin Receptor Antagonists for Insomnia Sales by Region (2024-2034)
2.4.4 Global Orexin Receptor Antagonists for Insomnia Sales Market Share by Region (2024-2034)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Orexin Receptor Antagonists for Insomnia Sales by Manufacturers
3.1.1 Global Orexin Receptor Antagonists for Insomnia Sales by Manufacturers (2024-2024)
3.1.2 Global Orexin Receptor Antagonists for Insomnia Sales Market Share by Manufacturers (2024-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Orexin Receptor Antagonists for Insomnia in 2022
3.2 Global Orexin Receptor Antagonists for Insomnia Revenue by Manufacturers
3.2.1 Global Orexin Receptor Antagonists for Insomnia Revenue by Manufacturers (2024-2024)
3.2.2 Global Orexin Receptor Antagonists for Insomnia Revenue Market Share by Manufacturers (2024-2024)
3.2.3 Global Top 10 and Top 5 Companies by Orexin Receptor Antagonists for Insomnia Revenue in 2022
3.3 Global Key Players of Orexin Receptor Antagonists for Insomnia, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Orexin Receptor Antagonists for Insomnia Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Orexin Receptor Antagonists for Insomnia Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Orexin Receptor Antagonists for Insomnia, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Orexin Receptor Antagonists for Insomnia, Product Offered and Application
3.8 Global Key Manufacturers of Orexin Receptor Antagonists for Insomnia, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Orexin Receptor Antagonists for Insomnia Sales by Type
4.1.1 Global Orexin Receptor Antagonists for Insomnia Historical Sales by Type (2024-2024)
4.1.2 Global Orexin Receptor Antagonists for Insomnia Forecasted Sales by Type (2024-2034)
4.1.3 Global Orexin Receptor Antagonists for Insomnia Sales Market Share by Type (2024-2034)
4.2 Global Orexin Receptor Antagonists for Insomnia Revenue by Type
4.2.1 Global Orexin Receptor Antagonists for Insomnia Historical Revenue by Type (2024-2024)
4.2.2 Global Orexin Receptor Antagonists for Insomnia Forecasted Revenue by Type (2024-2034)
4.2.3 Global Orexin Receptor Antagonists for Insomnia Revenue Market Share by Type (2024-2034)
4.3 Global Orexin Receptor Antagonists for Insomnia Price by Type
4.3.1 Global Orexin Receptor Antagonists for Insomnia Price by Type (2024-2024)
4.3.2 Global Orexin Receptor Antagonists for Insomnia Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Orexin Receptor Antagonists for Insomnia Sales by Application
5.1.1 Global Orexin Receptor Antagonists for Insomnia Historical Sales by Application (2024-2024)
5.1.2 Global Orexin Receptor Antagonists for Insomnia Forecasted Sales by Application (2024-2034)
5.1.3 Global Orexin Receptor Antagonists for Insomnia Sales Market Share by Application (2024-2034)
5.2 Global Orexin Receptor Antagonists for Insomnia Revenue by Application
5.2.1 Global Orexin Receptor Antagonists for Insomnia Historical Revenue by Application (2024-2024)
5.2.2 Global Orexin Receptor Antagonists for Insomnia Forecasted Revenue by Application (2024-2034)
5.2.3 Global Orexin Receptor Antagonists for Insomnia Revenue Market Share by Application (2024-2034)
5.3 Global Orexin Receptor Antagonists for Insomnia Price by Application
5.3.1 Global Orexin Receptor Antagonists for Insomnia Price by Application (2024-2024)
5.3.2 Global Orexin Receptor Antagonists for Insomnia Price Forecast by Application (2024-2034)
6 US & Canada
6.1 US & Canada Orexin Receptor Antagonists for Insomnia Market Size by Type
6.1.1 US & Canada Orexin Receptor Antagonists for Insomnia Sales by Type (2024-2034)
6.1.2 US & Canada Orexin Receptor Antagonists for Insomnia Revenue by Type (2024-2034)
6.2 US & Canada Orexin Receptor Antagonists for Insomnia Market Size by Application
6.2.1 US & Canada Orexin Receptor Antagonists for Insomnia Sales by Application (2024-2034)
6.2.2 US & Canada Orexin Receptor Antagonists for Insomnia Revenue by Application (2024-2034)
6.3 US & Canada Orexin Receptor Antagonists for Insomnia Market Size by Country
6.3.1 US & Canada Orexin Receptor Antagonists for Insomnia Revenue by Country: 2024 VS 2022 VS 2034
6.3.2 US & Canada Orexin Receptor Antagonists for Insomnia Sales by Country (2024-2034)
6.3.3 US & Canada Orexin Receptor Antagonists for Insomnia Revenue by Country (2024-2034)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Orexin Receptor Antagonists for Insomnia Market Size by Type
7.1.1 Europe Orexin Receptor Antagonists for Insomnia Sales by Type (2024-2034)
7.1.2 Europe Orexin Receptor Antagonists for Insomnia Revenue by Type (2024-2034)
7.2 Europe Orexin Receptor Antagonists for Insomnia Market Size by Application
7.2.1 Europe Orexin Receptor Antagonists for Insomnia Sales by Application (2024-2034)
7.2.2 Europe Orexin Receptor Antagonists for Insomnia Revenue by Application (2024-2034)
7.3 Europe Orexin Receptor Antagonists for Insomnia Market Size by Country
7.3.1 Europe Orexin Receptor Antagonists for Insomnia Revenue by Country: 2024 VS 2022 VS 2034
7.3.2 Europe Orexin Receptor Antagonists for Insomnia Sales by Country (2024-2034)
7.3.3 Europe Orexin Receptor Antagonists for Insomnia Revenue by Country (2024-2034)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Orexin Receptor Antagonists for Insomnia Market Size
8.1.1 China Orexin Receptor Antagonists for Insomnia Sales (2024-2034)
8.1.2 China Orexin Receptor Antagonists for Insomnia Revenue (2024-2034)
8.2 China Orexin Receptor Antagonists for Insomnia Market Size by Application
8.2.1 China Orexin Receptor Antagonists for Insomnia Sales by Application (2024-2034)
8.2.2 China Orexin Receptor Antagonists for Insomnia Revenue by Application (2024-2034)
9 Asia (excluding China)
9.1 Asia Orexin Receptor Antagonists for Insomnia Market Size by Type
9.1.1 Asia Orexin Receptor Antagonists for Insomnia Sales by Type (2024-2034)
9.1.2 Asia Orexin Receptor Antagonists for Insomnia Revenue by Type (2024-2034)
9.2 Asia Orexin Receptor Antagonists for Insomnia Market Size by Application
9.2.1 Asia Orexin Receptor Antagonists for Insomnia Sales by Application (2024-2034)
9.2.2 Asia Orexin Receptor Antagonists for Insomnia Revenue by Application (2024-2034)
9.3 Asia Orexin Receptor Antagonists for Insomnia Sales by Region
9.3.1 Asia Orexin Receptor Antagonists for Insomnia Revenue by Region: 2024 VS 2022 VS 2034
9.3.2 Asia Orexin Receptor Antagonists for Insomnia Revenue by Region (2024-2034)
9.3.3 Asia Orexin Receptor Antagonists for Insomnia Sales by Region (2024-2034)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Orexin Receptor Antagonists for Insomnia Market Size by Type
10.1.1 Middle East, Africa and Latin America Orexin Receptor Antagonists for Insomnia Sales by Type (2024-2034)
10.1.2 Middle East, Africa and Latin America Orexin Receptor Antagonists for Insomnia Revenue by Type (2024-2034)
10.2 Middle East, Africa and Latin America Orexin Receptor Antagonists for Insomnia Market Size by Application
10.2.1 Middle East, Africa and Latin America Orexin Receptor Antagonists for Insomnia Sales by Application (2024-2034)
10.2.2 Middle East, Africa and Latin America Orexin Receptor Antagonists for Insomnia Revenue by Application (2024-2034)
10.3 Middle East, Africa and Latin America Orexin Receptor Antagonists for Insomnia Sales by Country
10.3.1 Middle East, Africa and Latin America Orexin Receptor Antagonists for Insomnia Revenue by Country: 2024 VS 2022 VS 2034
10.3.2 Middle East, Africa and Latin America Orexin Receptor Antagonists for Insomnia Revenue by Country (2024-2034)
10.3.3 Middle East, Africa and Latin America Orexin Receptor Antagonists for Insomnia Sales by Country (2024-2034)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 MSD
11.1.1 MSD Company Information
11.1.2 MSD Overview
11.1.3 MSD Orexin Receptor Antagonists for Insomnia Sales, Price, Revenue and Gross Margin (2024-2024)
11.1.4 MSD Orexin Receptor Antagonists for Insomnia Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 MSD Recent Developments
11.2 Eisai Co., Ltd.
11.2.1 Eisai Co., Ltd. Company Information
11.2.2 Eisai Co., Ltd. Overview
11.2.3 Eisai Co., Ltd. Orexin Receptor Antagonists for Insomnia Sales, Price, Revenue and Gross Margin (2024-2024)
11.2.4 Eisai Co., Ltd. Orexin Receptor Antagonists for Insomnia Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Eisai Co., Ltd. Recent Developments
11.3 Idorsia
11.3.1 Idorsia Company Information
11.3.2 Idorsia Overview
11.3.3 Idorsia Orexin Receptor Antagonists for Insomnia Sales, Price, Revenue and Gross Margin (2024-2024)
11.3.4 Idorsia Orexin Receptor Antagonists for Insomnia Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Idorsia Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Orexin Receptor Antagonists for Insomnia Industry Chain Analysis
12.2 Orexin Receptor Antagonists for Insomnia Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Orexin Receptor Antagonists for Insomnia Production Mode & Process
12.4 Orexin Receptor Antagonists for Insomnia Sales and Marketing
12.4.1 Orexin Receptor Antagonists for Insomnia Sales Channels
12.4.2 Orexin Receptor Antagonists for Insomnia Distributors
12.5 Orexin Receptor Antagonists for Insomnia Customers
13 Market Dynamics
13.1 Orexin Receptor Antagonists for Insomnia Industry Trends
13.2 Orexin Receptor Antagonists for Insomnia Market Drivers
13.3 Orexin Receptor Antagonists for Insomnia Market Challenges
13.4 Orexin Receptor Antagonists for Insomnia Market Restraints
14 Key Findings in The Global Orexin Receptor Antagonists for Insomnia Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Orexin Receptor Antagonists for Insomnia Market Size Growth Rate by Type, 2024 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of OX1R
Table 3. Major Manufacturers of OX2R
Table 4. Global Orexin Receptor Antagonists for Insomnia Market Size Growth Rate by Application, 2024 VS 2022 VS 2034 (US$ Million)
Table 5. Global Orexin Receptor Antagonists for Insomnia Revenue Grow Rate (CAGR) by Region: 2024 VS 2022 VS 2034 (US$ Million)
Table 6. Global Orexin Receptor Antagonists for Insomnia Revenue by Region (2024-2024) & (US$ Million)
Table 7. Global Orexin Receptor Antagonists for Insomnia Revenue by Region (2024-2034) & (US$ Million)
Table 8. Global Orexin Receptor Antagonists for Insomnia Revenue Market Share by Region (2024-2024)
Table 9. Global Orexin Receptor Antagonists for Insomnia Revenue Market Share by Region (2024-2034)
Table 10. Global Orexin Receptor Antagonists for Insomnia Sales Grow Rate (CAGR) by Region: 2024 VS 2022 VS 2034 (US$ Million)
Table 11. Global Orexin Receptor Antagonists for Insomnia Sales by Region (2024-2024) & (K Units)
Table 12. Global Orexin Receptor Antagonists for Insomnia Sales by Region (2024-2034) & (K Units)
Table 13. Global Orexin Receptor Antagonists for Insomnia Sales Market Share by Region (2024-2024)
Table 14. Global Orexin Receptor Antagonists for Insomnia Sales Market Share by Region (2024-2034)
Table 15. Global Orexin Receptor Antagonists for Insomnia Sales by Manufacturers (2024-2024) & (K Units)
Table 16. Global Orexin Receptor Antagonists for Insomnia Sales Share by Manufacturers (2024-2024)
Table 17. Global Orexin Receptor Antagonists for Insomnia Revenue by Manufacturers (2024-2024) & (US$ Million)
Table 18. Global Orexin Receptor Antagonists for Insomnia Revenue Share by Manufacturers (2024-2024)
Table 19. Global Key Players of Orexin Receptor Antagonists for Insomnia, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Orexin Receptor Antagonists for Insomnia Price by Manufacturers 2024-2024 (US$/Unit)
Table 21. Global Orexin Receptor Antagonists for Insomnia Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Orexin Receptor Antagonists for Insomnia by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Orexin Receptor Antagonists for Insomnia as of 2022)
Table 23. Global Key Manufacturers of Orexin Receptor Antagonists for Insomnia, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Orexin Receptor Antagonists for Insomnia, Product Offered and Application
Table 25. Global Key Manufacturers of Orexin Receptor Antagonists for Insomnia, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Orexin Receptor Antagonists for Insomnia Sales by Type (2024-2024) & (K Units)
Table 28. Global Orexin Receptor Antagonists for Insomnia Sales by Type (2024-2034) & (K Units)
Table 29. Global Orexin Receptor Antagonists for Insomnia Sales Share by Type (2024-2024)
Table 30. Global Orexin Receptor Antagonists for Insomnia Sales Share by Type (2024-2034)
Table 31. Global Orexin Receptor Antagonists for Insomnia Revenue by Type (2024-2024) & (US$ Million)
Table 32. Global Orexin Receptor Antagonists for Insomnia Revenue by Type (2024-2034) & (US$ Million)
Table 33. Global Orexin Receptor Antagonists for Insomnia Revenue Share by Type (2024-2024)
Table 34. Global Orexin Receptor Antagonists for Insomnia Revenue Share by Type (2024-2034)
Table 35. Orexin Receptor Antagonists for Insomnia Price by Type (2024-2024) & (US$/Unit)
Table 36. Global Orexin Receptor Antagonists for Insomnia Price Forecast by Type (2024-2034) & (US$/Unit)
Table 37. Global Orexin Receptor Antagonists for Insomnia Sales by Application (2024-2024) & (K Units)
Table 38. Global Orexin Receptor Antagonists for Insomnia Sales by Application (2024-2034) & (K Units)
Table 39. Global Orexin Receptor Antagonists for Insomnia Sales Share by Application (2024-2024)
Table 40. Global Orexin Receptor Antagonists for Insomnia Sales Share by Application (2024-2034)
Table 41. Global Orexin Receptor Antagonists for Insomnia Revenue by Application (2024-2024) & (US$ Million)
Table 42. Global Orexin Receptor Antagonists for Insomnia Revenue by Application (2024-2034) & (US$ Million)
Table 43. Global Orexin Receptor Antagonists for Insomnia Revenue Share by Application (2024-2024)
Table 44. Global Orexin Receptor Antagonists for Insomnia Revenue Share by Application (2024-2034)
Table 45. Orexin Receptor Antagonists for Insomnia Price by Application (2024-2024) & (US$/Unit)
Table 46. Global Orexin Receptor Antagonists for Insomnia Price Forecast by Application (2024-2034) & (US$/Unit)
Table 47. US & Canada Orexin Receptor Antagonists for Insomnia Sales by Type (2024-2024) & (K Units)
Table 48. US & Canada Orexin Receptor Antagonists for Insomnia Sales by Type (2024-2034) & (K Units)
Table 49. US & Canada Orexin Receptor Antagonists for Insomnia Revenue by Type (2024-2024) & (US$ Million)
Table 50. US & Canada Orexin Receptor Antagonists for Insomnia Revenue by Type (2024-2034) & (US$ Million)
Table 51. US & Canada Orexin Receptor Antagonists for Insomnia Sales by Application (2024-2024) & (K Units)
Table 52. US & Canada Orexin Receptor Antagonists for Insomnia Sales by Application (2024-2034) & (K Units)
Table 53. US & Canada Orexin Receptor Antagonists for Insomnia Revenue by Application (2024-2024) & (US$ Million)
Table 54. US & Canada Orexin Receptor Antagonists for Insomnia Revenue by Application (2024-2034) & (US$ Million)
Table 55. US & Canada Orexin Receptor Antagonists for Insomnia Revenue Grow Rate (CAGR) by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 56. US & Canada Orexin Receptor Antagonists for Insomnia Revenue by Country (2024-2024) & (US$ Million)
Table 57. US & Canada Orexin Receptor Antagonists for Insomnia Revenue by Country (2024-2034) & (US$ Million)
Table 58. US & Canada Orexin Receptor Antagonists for Insomnia Sales by Country (2024-2024) & (K Units)
Table 59. US & Canada Orexin Receptor Antagonists for Insomnia Sales by Country (2024-2034) & (K Units)
Table 60. Europe Orexin Receptor Antagonists for Insomnia Sales by Type (2024-2024) & (K Units)
Table 61. Europe Orexin Receptor Antagonists for Insomnia Sales by Type (2024-2034) & (K Units)
Table 62. Europe Orexin Receptor Antagonists for Insomnia Revenue by Type (2024-2024) & (US$ Million)
Table 63. Europe Orexin Receptor Antagonists for Insomnia Revenue by Type (2024-2034) & (US$ Million)
Table 64. Europe Orexin Receptor Antagonists for Insomnia Sales by Application (2024-2024) & (K Units)
Table 65. Europe Orexin Receptor Antagonists for Insomnia Sales by Application (2024-2034) & (K Units)
Table 66. Europe Orexin Receptor Antagonists for Insomnia Revenue by Application (2024-2024) & (US$ Million)
Table 67. Europe Orexin Receptor Antagonists for Insomnia Revenue by Application (2024-2034) & (US$ Million)
Table 68. Europe Orexin Receptor Antagonists for Insomnia Revenue Grow Rate (CAGR) by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 69. Europe Orexin Receptor Antagonists for Insomnia Revenue by Country (2024-2024) & (US$ Million)
Table 70. Europe Orexin Receptor Antagonists for Insomnia Revenue by Country (2024-2034) & (US$ Million)
Table 71. Europe Orexin Receptor Antagonists for Insomnia Sales by Country (2024-2024) & (K Units)
Table 72. Europe Orexin Receptor Antagonists for Insomnia Sales by Country (2024-2034) & (K Units)
Table 73. China Orexin Receptor Antagonists for Insomnia Sales by Type (2024-2024) & (K Units)
Table 74. China Orexin Receptor Antagonists for Insomnia Sales by Type (2024-2034) & (K Units)
Table 75. China Orexin Receptor Antagonists for Insomnia Revenue by Type (2024-2024) & (US$ Million)
Table 76. China Orexin Receptor Antagonists for Insomnia Revenue by Type (2024-2034) & (US$ Million)
Table 77. China Orexin Receptor Antagonists for Insomnia Sales by Application (2024-2024) & (K Units)
Table 78. China Orexin Receptor Antagonists for Insomnia Sales by Application (2024-2034) & (K Units)
Table 79. China Orexin Receptor Antagonists for Insomnia Revenue by Application (2024-2024) & (US$ Million)
Table 80. China Orexin Receptor Antagonists for Insomnia Revenue by Application (2024-2034) & (US$ Million)
Table 81. Asia Orexin Receptor Antagonists for Insomnia Sales by Type (2024-2024) & (K Units)
Table 82. Asia Orexin Receptor Antagonists for Insomnia Sales by Type (2024-2034) & (K Units)
Table 83. Asia Orexin Receptor Antagonists for Insomnia Revenue by Type (2024-2024) & (US$ Million)
Table 84. Asia Orexin Receptor Antagonists for Insomnia Revenue by Type (2024-2034) & (US$ Million)
Table 85. Asia Orexin Receptor Antagonists for Insomnia Sales by Application (2024-2024) & (K Units)
Table 86. Asia Orexin Receptor Antagonists for Insomnia Sales by Application (2024-2034) & (K Units)
Table 87. Asia Orexin Receptor Antagonists for Insomnia Revenue by Application (2024-2024) & (US$ Million)
Table 88. Asia Orexin Receptor Antagonists for Insomnia Revenue by Application (2024-2034) & (US$ Million)
Table 89. Asia Orexin Receptor Antagonists for Insomnia Revenue Grow Rate (CAGR) by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 90. Asia Orexin Receptor Antagonists for Insomnia Revenue by Region (2024-2024) & (US$ Million)
Table 91. Asia Orexin Receptor Antagonists for Insomnia Revenue by Region (2024-2034) & (US$ Million)
Table 92. Asia Orexin Receptor Antagonists for Insomnia Sales by Region (2024-2024) & (K Units)
Table 93. Asia Orexin Receptor Antagonists for Insomnia Sales by Region (2024-2034) & (K Units)
Table 94. Middle East, Africa and Latin America Orexin Receptor Antagonists for Insomnia Sales by Type (2024-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Orexin Receptor Antagonists for Insomnia Sales by Type (2024-2034) & (K Units)
Table 96. Middle East, Africa and Latin America Orexin Receptor Antagonists for Insomnia Revenue by Type (2024-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Orexin Receptor Antagonists for Insomnia Revenue by Type (2024-2034) & (US$ Million)
Table 98. Middle East, Africa and Latin America Orexin Receptor Antagonists for Insomnia Sales by Application (2024-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Orexin Receptor Antagonists for Insomnia Sales by Application (2024-2034) & (K Units)
Table 100. Middle East, Africa and Latin America Orexin Receptor Antagonists for Insomnia Revenue by Application (2024-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Orexin Receptor Antagonists for Insomnia Revenue by Application (2024-2034) & (US$ Million)
Table 102. Middle East, Africa and Latin America Orexin Receptor Antagonists for Insomnia Revenue Grow Rate (CAGR) by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 103. Middle East, Africa and Latin America Orexin Receptor Antagonists for Insomnia Revenue by Country (2024-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Orexin Receptor Antagonists for Insomnia Revenue by Country (2024-2034) & (US$ Million)
Table 105. Middle East, Africa and Latin America Orexin Receptor Antagonists for Insomnia Sales by Country (2024-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Orexin Receptor Antagonists for Insomnia Sales by Country (2024-2034) & (K Units)
Table 107. MSD Company Information
Table 108. MSD Description and Major Businesses
Table 109. MSD Orexin Receptor Antagonists for Insomnia Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 110. MSD Orexin Receptor Antagonists for Insomnia Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. MSD Recent Developments
Table 112. Eisai Co., Ltd. Company Information
Table 113. Eisai Co., Ltd. Description and Major Businesses
Table 114. Eisai Co., Ltd. Orexin Receptor Antagonists for Insomnia Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 115. Eisai Co., Ltd. Orexin Receptor Antagonists for Insomnia Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Eisai Co., Ltd. Recent Developments
Table 117. Idorsia Company Information
Table 118. Idorsia Description and Major Businesses
Table 119. Idorsia Orexin Receptor Antagonists for Insomnia Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 120. Idorsia Orexin Receptor Antagonists for Insomnia Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Idorsia Recent Developments
Table 122. Key Raw Materials Lists
Table 123. Raw Materials Key Suppliers Lists
Table 124. Orexin Receptor Antagonists for Insomnia Distributors List
Table 125. Orexin Receptor Antagonists for Insomnia Customers List
Table 126. Orexin Receptor Antagonists for Insomnia Market Trends
Table 127. Orexin Receptor Antagonists for Insomnia Market Drivers
Table 128. Orexin Receptor Antagonists for Insomnia Market Challenges
Table 129. Orexin Receptor Antagonists for Insomnia Market Restraints
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Orexin Receptor Antagonists for Insomnia Product Picture
Figure 2. Global Orexin Receptor Antagonists for Insomnia Market Size Growth Rate by Type, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Orexin Receptor Antagonists for Insomnia Market Share by Type in 2022 & 2034
Figure 4. OX1R Product Picture
Figure 5. OX2R Product Picture
Figure 6. Global Orexin Receptor Antagonists for Insomnia Market Size Growth Rate by Application, 2024 VS 2022 VS 2034 (US$ Million)
Figure 7. Global Orexin Receptor Antagonists for Insomnia Market Share by Application in 2022 & 2034
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Other
Figure 11. Orexin Receptor Antagonists for Insomnia Report Years Considered
Figure 12. Global Orexin Receptor Antagonists for Insomnia Revenue, (US$ Million), 2024 VS 2022 VS 2034
Figure 13. Global Orexin Receptor Antagonists for Insomnia Revenue 2024-2034 (US$ Million)
Figure 14. Global Orexin Receptor Antagonists for Insomnia Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 15. Global Orexin Receptor Antagonists for Insomnia Revenue Market Share by Region (2024-2034)
Figure 16. Global Orexin Receptor Antagonists for Insomnia Sales 2024-2034 ((K Units)
Figure 17. Global Orexin Receptor Antagonists for Insomnia Sales Market Share by Region (2024-2034)
Figure 18. US & Canada Orexin Receptor Antagonists for Insomnia Sales YoY (2024-2034) & (K Units)
Figure 19. US & Canada Orexin Receptor Antagonists for Insomnia Revenue YoY (2024-2034) & (US$ Million)
Figure 20. Europe Orexin Receptor Antagonists for Insomnia Sales YoY (2024-2034) & (K Units)
Figure 21. Europe Orexin Receptor Antagonists for Insomnia Revenue YoY (2024-2034) & (US$ Million)
Figure 22. China Orexin Receptor Antagonists for Insomnia Sales YoY (2024-2034) & (K Units)
Figure 23. China Orexin Receptor Antagonists for Insomnia Revenue YoY (2024-2034) & (US$ Million)
Figure 24. Asia (excluding China) Orexin Receptor Antagonists for Insomnia Sales YoY (2024-2034) & (K Units)
Figure 25. Asia (excluding China) Orexin Receptor Antagonists for Insomnia Revenue YoY (2024-2034) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Orexin Receptor Antagonists for Insomnia Sales YoY (2024-2034) & (K Units)
Figure 27. Middle East, Africa and Latin America Orexin Receptor Antagonists for Insomnia Revenue YoY (2024-2034) & (US$ Million)
Figure 28. The Orexin Receptor Antagonists for Insomnia Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 29. The Top 5 and 10 Largest Manufacturers of Orexin Receptor Antagonists for Insomnia in the World: Market Share by Orexin Receptor Antagonists for Insomnia Revenue in 2022
Figure 30. Global Orexin Receptor Antagonists for Insomnia Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 31. Global Orexin Receptor Antagonists for Insomnia Sales Market Share by Type (2024-2034)
Figure 32. Global Orexin Receptor Antagonists for Insomnia Revenue Market Share by Type (2024-2034)
Figure 33. Global Orexin Receptor Antagonists for Insomnia Sales Market Share by Application (2024-2034)
Figure 34. Global Orexin Receptor Antagonists for Insomnia Revenue Market Share by Application (2024-2034)
Figure 35. US & Canada Orexin Receptor Antagonists for Insomnia Sales Market Share by Type (2024-2034)
Figure 36. US & Canada Orexin Receptor Antagonists for Insomnia Revenue Market Share by Type (2024-2034)
Figure 37. US & Canada Orexin Receptor Antagonists for Insomnia Sales Market Share by Application (2024-2034)
Figure 38. US & Canada Orexin Receptor Antagonists for Insomnia Revenue Market Share by Application (2024-2034)
Figure 39. US & Canada Orexin Receptor Antagonists for Insomnia Revenue Share by Country (2024-2034)
Figure 40. US & Canada Orexin Receptor Antagonists for Insomnia Sales Share by Country (2024-2034)
Figure 41. U.S. Orexin Receptor Antagonists for Insomnia Revenue (2024-2034) & (US$ Million)
Figure 42. Canada Orexin Receptor Antagonists for Insomnia Revenue (2024-2034) & (US$ Million)
Figure 43. Europe Orexin Receptor Antagonists for Insomnia Sales Market Share by Type (2024-2034)
Figure 44. Europe Orexin Receptor Antagonists for Insomnia Revenue Market Share by Type (2024-2034)
Figure 45. Europe Orexin Receptor Antagonists for Insomnia Sales Market Share by Application (2024-2034)
Figure 46. Europe Orexin Receptor Antagonists for Insomnia Revenue Market Share by Application (2024-2034)
Figure 47. Europe Orexin Receptor Antagonists for Insomnia Revenue Share by Country (2024-2034)
Figure 48. Europe Orexin Receptor Antagonists for Insomnia Sales Share by Country (2024-2034)
Figure 49. Germany Orexin Receptor Antagonists for Insomnia Revenue (2024-2034) & (US$ Million)
Figure 50. France Orexin Receptor Antagonists for Insomnia Revenue (2024-2034) & (US$ Million)
Figure 51. U.K. Orexin Receptor Antagonists for Insomnia Revenue (2024-2034) & (US$ Million)
Figure 52. Italy Orexin Receptor Antagonists for Insomnia Revenue (2024-2034) & (US$ Million)
Figure 53. Russia Orexin Receptor Antagonists for Insomnia Revenue (2024-2034) & (US$ Million)
Figure 54. China Orexin Receptor Antagonists for Insomnia Sales Market Share by Type (2024-2034)
Figure 55. China Orexin Receptor Antagonists for Insomnia Revenue Market Share by Type (2024-2034)
Figure 56. China Orexin Receptor Antagonists for Insomnia Sales Market Share by Application (2024-2034)
Figure 57. China Orexin Receptor Antagonists for Insomnia Revenue Market Share by Application (2024-2034)
Figure 58. Asia Orexin Receptor Antagonists for Insomnia Sales Market Share by Type (2024-2034)
Figure 59. Asia Orexin Receptor Antagonists for Insomnia Revenue Market Share by Type (2024-2034)
Figure 60. Asia Orexin Receptor Antagonists for Insomnia Sales Market Share by Application (2024-2034)
Figure 61. Asia Orexin Receptor Antagonists for Insomnia Revenue Market Share by Application (2024-2034)
Figure 62. Asia Orexin Receptor Antagonists for Insomnia Revenue Share by Region (2024-2034)
Figure 63. Asia Orexin Receptor Antagonists for Insomnia Sales Share by Region (2024-2034)
Figure 64. Japan Orexin Receptor Antagonists for Insomnia Revenue (2024-2034) & (US$ Million)
Figure 65. South Korea Orexin Receptor Antagonists for Insomnia Revenue (2024-2034) & (US$ Million)
Figure 66. China Taiwan Orexin Receptor Antagonists for Insomnia Revenue (2024-2034) & (US$ Million)
Figure 67. Southeast Asia Orexin Receptor Antagonists for Insomnia Revenue (2024-2034) & (US$ Million)
Figure 68. India Orexin Receptor Antagonists for Insomnia Revenue (2024-2034) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Orexin Receptor Antagonists for Insomnia Sales Market Share by Type (2024-2034)
Figure 70. Middle East, Africa and Latin America Orexin Receptor Antagonists for Insomnia Revenue Market Share by Type (2024-2034)
Figure 71. Middle East, Africa and Latin America Orexin Receptor Antagonists for Insomnia Sales Market Share by Application (2024-2034)
Figure 72. Middle East, Africa and Latin America Orexin Receptor Antagonists for Insomnia Revenue Market Share by Application (2024-2034)
Figure 73. Middle East, Africa and Latin America Orexin Receptor Antagonists for Insomnia Revenue Share by Country (2024-2034)
Figure 74. Middle East, Africa and Latin America Orexin Receptor Antagonists for Insomnia Sales Share by Country (2024-2034)
Figure 75. Brazil Orexin Receptor Antagonists for Insomnia Revenue (2024-2034) & (US$ Million)
Figure 76. Mexico Orexin Receptor Antagonists for Insomnia Revenue (2024-2034) & (US$ Million)
Figure 77. Turkey Orexin Receptor Antagonists for Insomnia Revenue (2024-2034) & (US$ Million)
Figure 78. Israel Orexin Receptor Antagonists for Insomnia Revenue (2024-2034) & (US$ Million)
Figure 79. GCC Countries Orexin Receptor Antagonists for Insomnia Revenue (2024-2034) & (US$ Million)
Figure 80. Orexin Receptor Antagonists for Insomnia Value Chain
Figure 81. Orexin Receptor Antagonists for Insomnia Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed